Madrigal Pharmaceuticals, Inc. Earnings logo

MDGL

Madrigal Pharmaceuticals, Inc. Earnings

$315.79

Earnings Summary

Revenue
$137.25Mn
Net Profits
$-73.24Mn
Net Profit Margins
-53.36%
Highlights
Revenue:

Madrigal Pharmaceuticals, Inc.’s revenue jumped +Inf% since last year same period to $137.25Mn in the Q1 2025. On a quarterly growth basis, Madrigal Pharmaceuticals, Inc. has generated 32.84% jump in its revenue since last 3-months.

Net Profits:

Madrigal Pharmaceuticals, Inc.’s net profit jumped 50.36% since last year same period to $-73.24Mn in the Q1 2025. On a quarterly growth basis, Madrigal Pharmaceuticals, Inc. has generated -23.26% fall in its net profits since last 3-months.

Net Profit Margins:

Madrigal Pharmaceuticals, Inc.’s net profit margin jumped NaN% since last year same period to -53.36% in the Q1 2025. On a quarterly growth basis, Madrigal Pharmaceuticals, Inc. has generated 7.21% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Madrigal Pharmaceuticals, Inc. post its latest quarter earnings
EPS Estimate Current Quarter
-3.36
EPS Estimate Current Year
-3.36
Highlights
EPS Estimate Current Quarter:

Madrigal Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -3.36 - a 5.88% jump from last quarter’s estimates.

EPS Estimate Current Year:

Madrigal Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -3.36.

Key Ratios

Key ratios of the Madrigal Pharmaceuticals, Inc. post its Q2 2025 earnings
Earning Per Share (EPS)
0
Highlights
Earning Per Share (EPS):

Madrigal Pharmaceuticals, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Madrigal Pharmaceuticals, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2025-08-06
-3.57
0
100%
2025-05-01
-6.28
-3.32
47.13%